New and updated fragment databases from ChEMBL and SureChEMBL are now available in Spark. This new release of databases significantly expands the available chemistry to Spark users by including the latest compounds from scientific literature, as well as previously unseen compounds from chemical patents. Combined with databases of fragments derived from screening compounds, and with custom databases which […]
New role will lead global commercial strategy and development as Optibrium continues to scale its drug discovery technologies and team Latest in a series of senior hires as the Company continues its rapid growth trajectory Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of […]
-Accelerating the development of small molecule drugs using materials informatics technology- Tokyo – Hitachi High-Tech Solutions Corporation (“Hitachi High-Tech Solutions”), in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commencing joint research that uses Materials Informatics (MI) (hereinafter, “the Research”) to improve the efficiency of the development of small molecule drugs*1. Hitachi […]
The world’s most trusted source for scientific information, CAS, leverages new content, technologies, and expertise to advance its life sciences growth initiative COLUMBUS, Ohio–CAS, a division of the American Chemical Society specializing in scientific information solutions, announced several initiatives to once again transform scientific research, and empower more rapid discovery for life sciences innovation. CAS […]
New role will lead technology development as the Company continues to scale team and global business operations Appointment of former Merck, Sharp and Dohme (MSD) Director of R&D Analytics supports continued innovation of Optibrium’s AI drug discovery software Cambridge, UK and Cambridge, US – Optibrium, a leading developer of software and AI solutions for drug discovery, […]
The $1.45 million grant from National Center for Advancing Translational Sciences will allow CDD to develop an intelligent chemical structure browser Burlingame, California — Collaborative Drug Discovery has received a $1.45 million grant from National Center for Advancing Translational Sciences to develop intelligent chemical structure browser for drug discovery. Collaborative Drug Discovery, Inc. (CDD) proposes […]
Establishment of Optibrium Inc. bolsters ongoing strategic Company growth and strengthens direct US customer support Dr Tamsin Mansley promoted to President of Optibrium Inc. to lead growing US-based team and business operations CAMBRIDGE, UK and CAMBRIDGE, US – Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today announced the opening […]
Enriching chemical structures with chemical domain information by calculated properties contributes to rationalizing workflows in chemistry. In order to increase the flexibility, access and integrability, Calculators and Predictors have been made available as a REST API SaaS via AWS Marketplace to offer a wide range of high-quality chemical descriptors including phys-chem properties, tautomerization and structural […]
Michelle Harrison appointed as Head of Strategic Marketing; Chris Khoury and Imran Ghauri join to boost Optibrium’s business development team UK and US-based appointments with proven AI and life science expertise will support the next phase of commercial growth for Optibrium’s computational drug discovery technologies CAMBRIDGE, UK – Optibrium, a leading developer of software and […]
Cresset, a drug discovery software scaleup, has raised growth capital from SEP to accelerate its product development and international expansion. Cresset, a UK-based developer of drug discovery and design software, announced it has secured investment from Scottish Equity Partners (SEP), a technology focused growth equity firm. The funding will be used to support Cresset’s vision […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
